These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 32565287)
1. Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions. Fan W; Yu Z; Peng H; He H; Lu Y; Qi J; Dong X; Zhao W; Wu W Int J Pharm; 2020 Aug; 586():119551. PubMed ID: 32565287 [TBL] [Abstract][Full Text] [Related]
2. Size-Dependent Translocation of Nanoemulsions via Oral Delivery. Xia F; Fan W; Jiang S; Ma Y; Lu Y; Qi J; Ahmad E; Dong X; Zhao W; Wu W ACS Appl Mater Interfaces; 2017 Jul; 9(26):21660-21672. PubMed ID: 28616962 [TBL] [Abstract][Full Text] [Related]
3. Dye-Loaded Nanoemulsions: Biomimetic Fluorescent Nanocarriers for Bioimaging and Nanomedicine. Klymchenko AS; Liu F; Collot M; Anton N Adv Healthc Mater; 2021 Jan; 10(1):e2001289. PubMed ID: 33052037 [TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Characterization of Folate-Targeted Platinum-Loaded Theranostic Nanoemulsions for Therapy and Imaging of Ovarian Cancer. Patel NR; Piroyan A; Nack AH; Galati CA; McHugh M; Orosz S; Keeler AW; O'Neal S; Zamboni WC; Davis B; Coleman TP Mol Pharm; 2016 Jun; 13(6):1996-2009. PubMed ID: 27170232 [TBL] [Abstract][Full Text] [Related]
5. Optimizing the Fluorescence Properties of Nanoemulsions for Single Particle Tracking in Live Cells. Wang X; Anton N; Ashokkumar P; Anton H; Fam TK; Vandamme T; Klymchenko AS; Collot M ACS Appl Mater Interfaces; 2019 Apr; 11(14):13079-13090. PubMed ID: 30844230 [TBL] [Abstract][Full Text] [Related]
6. Improved pharmacokinetic and biodistribution of 5-fluorouracil loaded biomimetic nanoerythrocytes decorated nanocarriers for liver cancer treatment. AlQahtani SA; Harisa GI; Alomrani AH; Alanazi FK; Badran MM Colloids Surf B Biointerfaces; 2021 Jan; 197():111380. PubMed ID: 33068824 [TBL] [Abstract][Full Text] [Related]
7. Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles. Ahmad E; Feng Y; Qi J; Fan W; Ma Y; He H; Xia F; Dong X; Zhao W; Lu Y; Wu W Nanoscale; 2017 Jan; 9(3):1174-1183. PubMed ID: 28009915 [TBL] [Abstract][Full Text] [Related]
9. Investigation of the "Nose-to-Brain" Pathways in Intranasal HupA Nanoemulsions and Evaluation of Their in vivo Pharmacokinetics and Brain-Targeting Ability. Jiang Y; Jiang Y; Ding Z; Yu Q Int J Nanomedicine; 2022; 17():3443-3456. PubMed ID: 35959279 [TBL] [Abstract][Full Text] [Related]
10. Preparation, preliminary pharmacokinetics and brain tissue distribution of Tanshinone IIA and Tetramethylpyrazine composite nanoemulsions. Wang B; Hong L; Liu Y; Bedingfield SK; Zhang C; Peng C; Qian J; Zha L Pharm Dev Technol; 2019 Dec; 24(10):1236-1242. PubMed ID: 31407940 [No Abstract] [Full Text] [Related]
11. Effect of phosphatidylcholine on the stability and lipolysis of nanoemulsion drug delivery systems. Zhang B; Zhou X; Miao Y; Wang X; Yang Y; Zhang X; Gan Y Int J Pharm; 2020 Jun; 583():119354. PubMed ID: 32348799 [TBL] [Abstract][Full Text] [Related]
12. Parenteral nanoemulsions as promising carriers for brain delivery of risperidone: Design, characterization and in vivo pharmacokinetic evaluation. Đorđević SM; Cekić ND; Savić MM; Isailović TM; Ranđelović DV; Marković BD; Savić SR; Timić Stamenić T; Daniels R; Savić SD Int J Pharm; 2015 Sep; 493(1-2):40-54. PubMed ID: 26209070 [TBL] [Abstract][Full Text] [Related]
13. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor. Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321 [TBL] [Abstract][Full Text] [Related]
14. Neuropharmacokinetic evaluation of lactoferrin-treated indinavir-loaded nanoemulsions: remarkable brain delivery enhancement. Karami Z; Saghatchi Zanjani MR; Rezaee S; Rostamizadeh K; Hamidi M Drug Dev Ind Pharm; 2019 May; 45(5):736-744. PubMed ID: 30640551 [TBL] [Abstract][Full Text] [Related]
15. Optimization of PEGylated nanoemulsions for improved pharmacokinetics of BCS class II compounds. Devalapally H; Zhou F; McDade J; Goloverda G; Owen A; Hidalgo IJ; Silchenko S Drug Deliv; 2015; 22(4):467-74. PubMed ID: 24344786 [TBL] [Abstract][Full Text] [Related]
16. Ovarian Accumulation of Nanoemulsions: Impact of Mice Age and Particle Size. Busmann EF; Kollan J; Mäder K; Lucas H Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361049 [TBL] [Abstract][Full Text] [Related]
17. Preparation of a cationic nanoemulsome for intratumoral drug delivery and its enhancing effect on cellular uptake in vitro. Li H; Xiao Y; Niu J; Chen X; Ping Q J Nanosci Nanotechnol; 2011 Oct; 11(10):8547-55. PubMed ID: 22400223 [TBL] [Abstract][Full Text] [Related]
18. Bioimaging of Intact Polycaprolactone Nanoparticles Using Aggregation-Caused Quenching Probes: Size-Dependent Translocation via Oral Delivery. He H; Xie Y; Lv Y; Qi J; Dong X; Zhao W; Wu W; Lu Y Adv Healthc Mater; 2018 Nov; 7(22):e1800711. PubMed ID: 30345713 [TBL] [Abstract][Full Text] [Related]
19. Nanoemulsions (NEs), liposomes (LPs) and solid lipid nanoparticles (SLNs) for retinyl palmitate: effect on skin permeation. Clares B; Calpena AC; Parra A; Abrego G; Alvarado H; Fangueiro JF; Souto EB Int J Pharm; 2014 Oct; 473(1-2):591-8. PubMed ID: 25102113 [TBL] [Abstract][Full Text] [Related]
20. Bile acid/fatty acid integrated nanoemulsomes for nonalcoholic fatty liver targeted lovastatin delivery: stability, Faran SA; Hussain T; Khalid SH; Khan IU; Asif M; Ahmad J; Rehman A; Asghar S Expert Opin Drug Deliv; 2024 May; 21(5):779-796. PubMed ID: 38795359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]